Yuval Horn, Keren Kanir and Uri Dotan of Horn & Co. represented Vascular Biogenics Ltd. in its $24 Million follow-on offering on NASDAQ
June 20, 2016
Yuval Horn participates in the WHO’S WHO LEGAL’S ROUNDTABLE: LIFE SCIENCES 2016
June 20, 2016
Horn & Co. listed by iam Magazine as one of top 3 “highly recommended” Israeli firms in the field of intellectual property transactions
May 31, 2016
Yuval Horn and Orly Sternfeld of Horn & Co. represented Zebra Medical Vision Ltd. in its Series B financing round
May 25, 2016
Yuval Horn and Orly Sternfeld of Horn & Co. represented Zebra Medical Vision Ltd. in its Series B financing round led by Intermountain Healthcare
May 25, 2016
Yuval Horn and Keren Margalit of Horn & Co. represented BioSight Ltd. in its Series B financing round led by Arkin Holdings and US based venture firm Primera Capital
May 18, 2016
Yuval Horn to moderate the corporate finance panel at the IBA 4th Annual World Life Sciences Conference on July 3, 2016 in San Francisco
May 4, 2016
Yuval Horn and Ohad Mamann of Horn & Co. represented the lead investors in cancer metabolism start-up Metabomed’s series A financing round
April 21, 2016
Yuval Horn will co-chair the 2nd Annual Mergers and Acquisitions in the Technology Sector Conference of the International Bar Association, to take place on October 27-28, 2016 in Tel Aviv
April 7, 2016
Adv. Orly Sternfeld joined the firm as a partner
January 17, 2016
